Google Alert - "Myeloproliferative neoplasms" OR "polycythemia vera" OR myelofibrosis OR "essential thrombocythemia" · Scour

Potential Rusfertide Approval May Offer More Control of Polycythemia Vera

Reassessing the Prognostic Weight of Anemia Plus Thrombocytopenia in Primary Myelofibrosis

Incyte's MutCALR Bet: S-Curve Inflection in MPN Infrastructure

Emerging Bladder Preservation Strategies for Patients With Muscle-Invasive Bladder Cancer

Determining Transplantation Needs and Risk Factors in Myelofibrosis Care

Incyte Corp Stock (ISIN: US45337C1027) Faces Pressure Amid Oncology Pipeline Setbacks ...

Rusfertide Approval Would Move Past 'Archaic' Polycythemia Vera Standard

Patients With MF May Need Different Therapies Based on Anemia Status

Momelotinib May Not Be Cost-Effective Intervention for Myelofibrosis or Anemia

Pacritinib in transplant-eligible myelofibrosis : final analysis of the phase II HOVON-134 trial

AN2 Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent ...

Sequential Transformation of Polycythemia Vera to Myelofibrosis and KMT2A-Rearranged ...

Ruxolitinib Regimens May Improve Myelofibrosis Treatment

AN2 Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent ...

Metformin Reduces BM Fibrosis and JAK-STAT Signaling in PMF

Itching could be a symptom of these 4 cancers according to oncologist

Rusfertide May Become Part of Polycythemia Vera Armamentarium

POIESIS: a phase III study of add-on navtemadlin in JAK inhibitor-naïve myelofibrosis ...

Shilpa Biologicals, mAbTree Program Targets Immune Pathway in Rare Blood Cancers

Protagonist Therapeutics Stock (ISIN: US74374T1097) Gains Momentum on Pipeline Progress

Log in to enable infinite scrolling